Discontinuation report ACT CELECOXIB

Last updated on 2020-09-03 History
Report ID 123648
Drug Identification Number 02420155
Brand name ACT CELECOXIB
Common or Proper name CELECOXIB 100MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CELECOXIB
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-02-28
Actual discontinuation date
Remaining supply date 2021-02-28
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments TO BE DISC
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-09-03 French Compare
v1 2020-09-03 English Compare